US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco SteelPath MLP & Energy Infrastructure ETF

26.60

+0.09000.34%

Volume:72.00

Turnover:1.93K

Market Cap:56.13M

PE:- -

High:26.60

Open:26.60

Low:26.60

Close:26.51

52wk High:26.60

52wk Low:21.07

Shares:2.11M

Float Shares:2.11M

Volume Ratio:0.54

T/O Rate:0.00%

Dividend:0.99

Dividend Rate:3.72%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Powell Max Raises $17 Million in PIPE and Overhauls Board in January 2026

Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline

NeOnc Technologies secures strategic PIPE investment from Cinctive Capital

Press Release: NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management

USA Rare Earth Announces Closing of $1.5 Billion PIPE Financing

Tamboran Director Increases Stake Through PIPE Share Issue

Galaxy Payroll Group Replaces 2025 PIPE With Discounted US$2.5 Million Share Offering

Curis Announces PIPE Financing and Strategic Capital Strengthening

How M&A Unlocked A Biotech Rebound In 2025— And What Comes Next?

Press Release: Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Linkage Global announces $1M PIPE financing

Press Release: Enlivex Announces $212,000,000 Private Placement to Initiate World's First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

Contineum Shares Fall After Phase 2 PIPE-307 Trial Fails to Meet Efficacy Goals in Multiple Sclerosis

MT Newswires Live

Contineum Therapeutics: Undervalued Potential in IPF with PIPE-791 Amidst PIPE-307 Setback

Positive Outlook on Contineum Therapeutics Despite Setbacks, Driven by PIPE-791’s Potential in IPF

Optimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

Merlin Labs Boosts PIPE Commitments for Growth

NextCure announces closing of $21.5M PIPE financing

Press Release: NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PIPE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PIPE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIPE\",,,,,undefined,":{"symbol":"PIPE","market":"US","secType":"STK","nameCN":"Invesco SteelPath MLP & Energy Infrastructure ETF","latestPrice":26.6,"timestamp":1770670800000,"preClose":26.51,"halted":0,"volume":72,"delay":0,"changeRate":0.003394945303658991,"floatShares":2110001,"shares":2110001,"eps":0,"marketStatus":"Pre-Mkt","change":0.09,"latestTime":"02-10 09:12:15 EST","open":26.6,"high":26.6,"low":26.6,"amount":1927.4473,"amplitude":0,"askPrice":51.62,"askSize":100,"bidPrice":16.92,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":26.6,"sharesOutstanding":2110001,"nav":26.62836,"aum":56185866.22836,"dividendRate":0.037207,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":26.6,"preClose":26.6,"latestTime":"16:10 EST","volume":4,"amount":107.5636,"timestamp":1770671404062,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5381164712743337},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIPE\",,,,,undefined,":{"symbol":"PIPE","floatShares":2110001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5381164712743337,"shares":2110001,"dividePrice":0.9897,"high":26.6,"amplitude":0,"preClose":26.51,"low":26.6,"week52Low":21.0715,"pbRate":"--","week52High":26.6,"institutionHeld":0,"latestPrice":26.6,"eps":0,"divideRate":0.037207,"volume":72,"delay":0,"ttmEps":0,"open":26.6,"prevYearClose":24.1698,"prevWeekClose":26.51,"prevMonthClose":25.825,"prevQuarterClose":24.1698,"fiveDayClose":25.5247,"twentyDayClose":23.83,"sixtyDayClose":23.6309},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIPE\",params:#limit:5,,,undefined,":[{"date":"2026-01-20","symbol":"PIPE","amount":0.09,"announcedDate":"2026-01-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-20","defaultRemindTime":1768919400000,"name":"Invesco SteelPath MLP & Energy Infrastructure ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-23","payableDate":"2026-01-20","currency":"USD","dateTimestamp":1768885200000,"payDate":"2026-01-23"},{"date":"2025-12-22","symbol":"PIPE","amount":0.09,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco SteelPath MLP & Energy Infrastructure ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-11-24","symbol":"PIPE","amount":0.09,"announcedDate":"2025-11-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-24","defaultRemindTime":1763994600000,"name":"Invesco SteelPath MLP & Energy Infrastructure ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-24","currency":"USD","dateTimestamp":1763960400000,"payDate":"2025-11-28"},{"date":"2025-10-20","symbol":"PIPE","amount":0.09,"announcedDate":"2025-10-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-20","defaultRemindTime":1760967000000,"name":"Invesco SteelPath MLP & Energy Infrastructure ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-24","payableDate":"2025-10-20","currency":"USD","dateTimestamp":1760932800000,"payDate":"2025-10-24"},{"date":"2025-09-22","symbol":"PIPE","amount":0.09,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco SteelPath MLP & Energy Infrastructure ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIPE\",market:\"US\",,,undefined,":[{"executeDate":"2025-03-24","recordDate":"2025-03-24","paymentDate":"2025-03-28","value":0.09,"currency":"USD"},{"executeDate":"2025-04-21","recordDate":"2025-04-21","paymentDate":"2025-04-25","value":0.09,"currency":"USD"},{"executeDate":"2025-05-19","recordDate":"2025-05-19","paymentDate":"2025-05-23","value":0.09,"currency":"USD"},{"executeDate":"2025-06-23","recordDate":"2025-06-23","paymentDate":"2025-06-27","value":0.09,"currency":"USD"},{"executeDate":"2025-07-21","recordDate":"2025-07-21","paymentDate":"2025-07-25","value":0.09,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PIPE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIPE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610642557","title":"Powell Max Raises $17 Million in PIPE and Overhauls Board in January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610642557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610642557?lang=en_us&edition=fundamental","pubTime":"2026-02-10 19:58","pubTimestamp":1770724684,"startTime":"0","endTime":"0","summary":"Powell Max Limited Class A ( ($PMAX) ) has issued an announcement. On January 29, 2026, Powell Max Limited entered into a $17 million private inves...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/powell-max-raises-17-million-in-pipe-and-overhauls-board-in-january-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/powell-max-raises-17-million-in-pipe-and-overhauls-board-in-january-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","US12M.BOND","US2Y.BOND","TLT","TMF","TLTW","US10Y.BOND","US7Y.BOND","BK4096","US30Y.BOND","US3Y.BOND","US5Y.BOND","US6M.BOND","PIPE","BK4588"],"gpt_icon":0},{"id":"2608386559","title":"Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2608386559","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608386559?lang=en_us&edition=fundamental","pubTime":"2026-02-04 06:10","pubTimestamp":1770156611,"startTime":"0","endTime":"0","summary":"Adlai Nortye Ltd. Sponsored ADR ( ($ANL) ) has provided an announcement. On February 3, 2026, Adlai Nortye Ltd. announced it had entered into secur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adlai-nortye-secures-140-million-pipe-financing-to-support-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adlai-nortye-secures-140-million-pipe-financing-to-support-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2133065610.SGD","PIPE","ALN","ANL","IE00BZ199S13.USD"],"gpt_icon":0},{"id":"2607049713","title":"NeOnc Technologies secures strategic PIPE investment from Cinctive Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049713","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607049713?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:17","pubTimestamp":1769782631,"startTime":"0","endTime":"0","summary":"NeOnc Technologies (NTHI) announced that it has entered into a securities purchase agreement for a private investment in public equity for the purc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neonc-technologies-secures-strategic-pipe-investment-from-cinctive-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neonc-technologies-secures-strategic-pipe-investment-from-cinctive-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIPE","NTHI","BK4007"],"gpt_icon":0},{"id":"2607461060","title":"Press Release: NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2607461060","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607461060?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:00","pubTimestamp":1769781600,"startTime":"0","endTime":"0","summary":"CALABASAS, Calif., Jan. 30, 2026  -- NeOnc Technologies Holdings, Inc.  , a multi-Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system  cancers, today announced that it has entered into a securities purchase agreement for a private investment in public equity  for the purchase and sale of up to 2,222,222 shares of common stock and five-year warrants to purchase up to 2,222,222 shares of common stock at a per share exercise price of $9.00 at a combined purchase price of $7.20, that is expected to result in gross proceeds of up to approximately $16 million to the Company. NeOnc currently intends to use the net proceeds from the offering for repayment of indebtedness, and for working capital and corporate purposes.Amir F. Heshmatpour, Executive Chairman, President & CEO of NeOnc Technologies Holdings, Inc., stated: \"This strategic investment from a firm of Cinctive Capital's caliber validates our technological approach and the potential of","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4099","BK4588","IND","NTHI","BK4135","CNS","PIPE","03160","BK4604","TM","BK4007","BK4555"],"gpt_icon":0},{"id":"2607913084","title":"USA Rare Earth Announces Closing of $1.5 Billion PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607913084","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607913084?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:01","pubTimestamp":1769688060,"startTime":"0","endTime":"0","summary":"STILLWATER, Okla., Jan.  29, 2026  (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the closing of its previously announced private investment in public e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/29/3228431/0/en/USA-Rare-Earth-Announces-Closing-of-1-5-Billion-PIPE-Financing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIPE"],"gpt_icon":0},{"id":"2606084382","title":"Tamboran Director Increases Stake Through PIPE Share Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2606084382","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606084382?lang=en_us&edition=fundamental","pubTime":"2026-01-27 14:27","pubTimestamp":1769495249,"startTime":"0","endTime":"0","summary":"Tamboran Resources Limited ( ($AU:TBN) ) has issued an announcement. Tamboran Resources Corporation has reported a change in the equity holdings of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tamboran-director-increases-stake-through-pipe-share-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tamboran-director-increases-stake-through-pipe-share-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","TBN","PIPE"],"gpt_icon":0},{"id":"2605871448","title":"Galaxy Payroll Group Replaces 2025 PIPE With Discounted US$2.5 Million Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2605871448","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605871448?lang=en_us&edition=fundamental","pubTime":"2026-01-23 05:58","pubTimestamp":1769119088,"startTime":"0","endTime":"0","summary":"Galaxy Payroll Group Limited ( ($GLXG) ) has provided an announcement. On January 21, 2026, Galaxy Payroll Group Limited terminated a previously an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galaxy-payroll-group-replaces-2025-pipe-with-discounted-us2-5-million-share-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galaxy-payroll-group-replaces-2025-pipe-with-discounted-us2-5-million-share-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIPE"],"gpt_icon":0},{"id":"2601483365","title":"Curis Announces PIPE Financing and Strategic Capital Strengthening","url":"https://stock-news.laohu8.com/highlight/detail?id=2601483365","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601483365?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:31","pubTimestamp":1767871889,"startTime":"0","endTime":"0","summary":"The latest update is out from Curis ( ($CRIS) ). On January 7, 2026, Curis entered into a private placement securities purchase agreement with heal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curis-announces-pipe-financing-and-strategic-capital-strengthening?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curis-announces-pipe-financing-and-strategic-capital-strengthening?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PIPE","CRIS"],"gpt_icon":0},{"id":"2600708565","title":"How M&A Unlocked A Biotech Rebound In 2025— And What Comes Next?","url":"https://stock-news.laohu8.com/highlight/detail?id=2600708565","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600708565?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:01","pubTimestamp":1767193260,"startTime":"0","endTime":"0","summary":"Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher— here's why.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/31/Portrait-Of-A-Multiethnic-Student-Workin.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/31/Portrait-Of-A-Multiethnic-Student-Workin.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/25/12/49648397/biotechs-comeback-year-how-ma-unlocked-a-rebound-in-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/12/49648397/biotechs-comeback-year-how-ma-unlocked-a-rebound-in-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["PIPE"],"gpt_icon":0},{"id":"2588753037","title":"Press Release: Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE","url":"https://stock-news.laohu8.com/highlight/detail?id=2588753037","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588753037?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:25","pubTimestamp":1764599100,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US, Inc.  announced a merger with MindWave Innovations Inc, uniting Apimeds' late-stage, non-opioid pain-management biologic portfolio with MindWave's AI-driven Bitcoin treasury, digital asset yield generation, and $NILA-powered ecosystem. The combined company integrates high-growth biotechnology and institutional digital-treasury capabilities, with the merger supported by a simultaneous PIPE of up to $100 million to advance Apimeds' clinical programs and expand MindWave's digital asset infrastructure. Apimeds Pharmaceuticals US, Inc. , a clinical-stage biotechnology company that completed its IPO in May 2025, today announced that it has merged with MindWave Innovations Inc . Today, Apimeds and MindWave signed the merger agreement  outlining the terms of the Merger, thus paving the way for a dual-growth enterprise spanning advanced biotechnology and institutional digital-asset treasury solutions.MindWave is a global leader in AI-driven Bitcoin and yield-generati","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIPE"],"gpt_icon":0},{"id":"2586297697","title":"Linkage Global announces $1M PIPE financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586297697","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586297697?lang=en_us&edition=fundamental","pubTime":"2025-11-27 09:55","pubTimestamp":1764208509,"startTime":"0","endTime":"0","summary":"Linkage Global (LGCB) announces the pricing of a private investment in public equity financing. On November 24, 2025, the Company entered into a se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/linkage-global-announces-1m-pipe-financing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/linkage-global-announces-1m-pipe-financing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGCB","PIPE","BK4220"],"gpt_icon":0},{"id":"2585846470","title":"Press Release: Enlivex Announces $212,000,000 Private Placement to Initiate World's First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2585846470","media":"Dow Jones","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585846470?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:55","pubTimestamp":1763988900,"startTime":"0","endTime":"0","summary":"- Upon the closing of the private placement, Enlivex will adopt the world's first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation.- RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation - built for transparency, automation, and community participation.- Mr. Matteo Renzi, former Prime Minister of Italy, will be appointed to the Enlivex Board of Directors following closing of the private placement.- Price per share of $1.00, representing a premium of 11.5% from previous closing price.\"With the recent institutional interest in leading prediction markets companies -- $2 billion investment by NYSE's parent company in Polymarket, and Kalshi's $300 million financing round led by Andreessen Horowitz  and Sequoia Capital -- it appears that this industry is maturing and has strong growth potential. We believe that following the closing of t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","US2Y.BOND","TMF","US30Y.BOND","US10Y.BOND","US3Y.BOND","ENLV","TLTW","BK4588","US7Y.BOND","BK4007","US12M.BOND","BK4555","BK4539","TM","BK4081","RAIN","PIPE","US6M.BOND","EMA","BK4099","03160","BK4585","BK4139","BK4604","US5Y.BOND"],"gpt_icon":1},{"id":"2585276123","title":"Contineum Shares Fall After Phase 2 PIPE-307 Trial Fails to Meet Efficacy Goals in Multiple Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2585276123","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585276123?lang=en_us&edition=fundamental","pubTime":"2025-11-22 04:18","pubTimestamp":1763756289,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics  shares were down about 10% in recent Friday trading after the company said late Thursday that its phase 2 trial of PIPE-307, in development for the treatment of patients with relapsing-remitting multiple sclerosis, failed to meet its primary and secondary efficacy goals.The company said PIPE-307 showed an acceptable safety and tolerability profile. Contineum said it is continuing to analyze exploratory endpoints and plans to present the full dataset at a future medical meeting.The company said it remains committed to pursuing novel therapies for patients with inflammatory and fibrotic diseases.Price: 10.93, Change: -1.29, Percent Change: -10.56","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIPE","BK4007","CTNM"],"gpt_icon":0},{"id":"2585143314","title":"Contineum Therapeutics: Undervalued Potential in IPF with PIPE-791 Amidst PIPE-307 Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2585143314","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585143314?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:55","pubTimestamp":1763729718,"startTime":"0","endTime":"0","summary":"Debanjana Chatterjee, an analyst from JonesTrading, reiterated the Buy rating on Contineum Therapeutics, Inc. Class A. The associated price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/contineum-therapeutics-undervalued-potential-in-ipf-with-pipe-791-amidst-pipe-307-setback-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/contineum-therapeutics-undervalued-potential-in-ipf-with-pipe-791-amidst-pipe-307-setback-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIPE","BK4007","CTNM"],"gpt_icon":0},{"id":"2585848110","title":"Positive Outlook on Contineum Therapeutics Despite Setbacks, Driven by PIPE-791’s Potential in IPF","url":"https://stock-news.laohu8.com/highlight/detail?id=2585848110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585848110?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:55","pubTimestamp":1763726151,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis has maintained their bullish stance on CTNM stock, giving a Buy rating yesterday. Paul Matteis has given his B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-on-contineum-therapeutics-despite-setbacks-driven-by-pipe-791s-potential-in-ipf-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-on-contineum-therapeutics-despite-setbacks-driven-by-pipe-791s-potential-in-ipf-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4007","PIPE"],"gpt_icon":0},{"id":"2585657811","title":"Optimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2585657811","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585657811?lang=en_us&edition=fundamental","pubTime":"2025-11-21 07:05","pubTimestamp":1763679930,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on CTNM stock, giving a Buy rating on November 6. Myles Minter has given his...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-contineum-therapeutics-amid-promising-pipe-791-developments-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-contineum-therapeutics-amid-promising-pipe-791-developments-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","PIPE"],"gpt_icon":0},{"id":"2584132481","title":"AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling","url":"https://stock-news.laohu8.com/highlight/detail?id=2584132481","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584132481?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:30","pubTimestamp":1763645400,"startTime":"0","endTime":"0","summary":"-First closing of PIPE resulted in ~$1.79M in proceeds - - FDA BPD Type 2a meeting now scheduled for January 21, 2026 - IRVINE, Calif., Nov.  20, 2025  (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3191914/0/en/AEON-Biopharma-Announces-First-Closing-of-PIPE-Investment-and-Provides-Update-on-FDA-Type-2a-Meeting-Scheduling.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIPE","AEON","BK4139"],"gpt_icon":0},{"id":"2584624706","title":"Merlin Labs Boosts PIPE Commitments for Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2584624706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584624706?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:45","pubTimestamp":1763390759,"startTime":"0","endTime":"0","summary":"The latest update is out from Bleichroeder Acquisition Corp. I Class A ( ($BACQ) ). On November 17, 2025, Merlin Labs and Inflection Point Acquisit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/merlin-labs-boosts-pipe-commitments-for-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/merlin-labs-boosts-pipe-commitments-for-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIPE"],"gpt_icon":0},{"id":"2584268116","title":"NextCure announces closing of $21.5M PIPE financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584268116","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584268116?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:16","pubTimestamp":1763385363,"startTime":"0","endTime":"0","summary":"NextCure (NXTC)announced the closing of its previously announced private placement in public equity. The PIPE was led by Ikarian Capital, Squadron ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nextcure-announces-closing-of-21-5m-pipe-financing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nextcure-announces-closing-of-21-5m-pipe-financing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXTC","BK4139","PIPE"],"gpt_icon":0},{"id":"2584625569","title":"Press Release: NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625569","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584625569?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:01","pubTimestamp":1763384460,"startTime":"0","endTime":"0","summary":"-- Extends cash runway into first half of 2027, beyond planned first half of. 2026 proof of concept  data readouts of SIM0505  and. -- Led by Ikarian Capital, Squadron Capital Management, Affinity Healthcare. Fund, and Exome Asset Management in a private placement of common stock. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","ADC","BK4139","BK4080","PIPE","BK4231"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":78,"code":"91000000","status":"200"}]}}